Literature DB >> 29356691

The epileptic encephalopathy jungle - from Dr West to the concepts of aetiology-related and developmental encephalopathies.

Judith Kalser1, J Helen Cross.   

Abstract

PURPOSE OF REVIEW: We aim to further disentangle the jungle of terminology of epileptic encephalopathy and provide some insights into the current understanding about the aetiology and pathophysiology of this process. We cover also the key features of epilepsy syndromes of infancy and childhood which are considered at high risk of developing an epileptic encephalopathy. RECENT
FINDINGS: The concept of 'epileptic encephalopathy' has progressively been elaborated by the International League Against Epilepsy according to growing clinical and laboratory evidence. It defines a process of neurological impairment caused by the epileptic activity itself and, therefore, potentially reversible with successful treatment, although to a variable extent. Epileptic activity interfering with neurogenesis, synaptogenesis, and normal network organization as well as triggering neuroinflammation are among the possible pathophysiological mechanisms leading to the neurological compromise. This differs from the newly introduced concept of 'developmental encephalopathy' which applies to where the epilepsy and developmental delay are both because of the underlying aetiology and aggressive antiepileptic treatment may not be helpful.
SUMMARY: The understanding and use of correct terminology is crucial in clinical practice enabling appropriate expectations of antiepileptic treatment. Further research is needed to elucidate underlying pathophysiological mechanisms, define clear outcome predictors, and find new treatment targets.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29356691     DOI: 10.1097/WCO.0000000000000535

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  7 in total

Review 1.  Does electroencephalographic burst suppression still play a role in the perioperative setting?

Authors:  Francisco Almeida Lobo; Susana Vacas; Andrea O Rossetti; Chiara Robba; Fabio Silvio Taccone
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-10-31

2.  Arx expansion mutation perturbs cortical development by augmenting apoptosis without activating innate immunity in a mouse model of X-linked infantile spasms syndrome.

Authors:  Meagan S Siehr; Cory A Massey; Jeffrey L Noebels
Journal:  Dis Model Mech       Date:  2020-03-30       Impact factor: 5.758

3.  DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification.

Authors:  Jenna M Lentini; Hessa S Alsaif; Eissa Faqeih; Fowzan S Alkuraya; Dragony Fu
Journal:  Nat Commun       Date:  2020-05-19       Impact factor: 14.919

4.  Phenotypic and Genotypic Spectrum of Early-Onset Developmental and Epileptic Encephalopathies-Data from a Romanian Cohort.

Authors:  Anca-Lelia Riza; Ioana Streață; Eugenia Roza; Magdalena Budișteanu; Catrinel Iliescu; Carmen Burloiu; Mihaela-Amelia Dobrescu; Stefania Dorobanțu; Adina Dragoș; Andra Grigorescu; Tiberiu Tătaru; Mihai Ioana; Raluca Teleanu
Journal:  Genes (Basel)       Date:  2022-07-15       Impact factor: 4.141

5.  Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases.

Authors:  Elena Perenthaler; Anita Nikoncuk; Soheil Yousefi; Woutje M Berdowski; Maysoon Alsagob; Ivan Capo; Herma C van der Linde; Paul van den Berg; Edwin H Jacobs; Darija Putar; Mehrnaz Ghazvini; Eleonora Aronica; Wilfred F J van IJcken; Walter G de Valk; Evita Medici-van den Herik; Marjon van Slegtenhorst; Lauren Brick; Mariya Kozenko; Jennefer N Kohler; Jonathan A Bernstein; Kristin G Monaghan; Amber Begtrup; Rebecca Torene; Amna Al Futaisi; Fathiya Al Murshedi; Renjith Mani; Faisal Al Azri; Erik-Jan Kamsteeg; Majid Mojarrad; Atieh Eslahi; Zaynab Khazaei; Fateme Massinaei Darmiyan; Mohammad Doosti; Ehsan Ghayoor Karimiani; Jana Vandrovcova; Faisal Zafar; Nuzhat Rana; Krishna K Kandaswamy; Jozef Hertecant; Peter Bauer; Mohammed A AlMuhaizea; Mustafa A Salih; Mazhor Aldosary; Rawan Almass; Laila Al-Quait; Wafa Qubbaj; Serdar Coskun; Khaled O Alahmadi; Muddathir H A Hamad; Salem Alwadaee; Khalid Awartani; Anas M Dababo; Futwan Almohanna; Dilek Colak; Mohammadreza Dehghani; Mohammad Yahya Vahidi Mehrjardi; Murat Gunel; A Gulhan Ercan-Sencicek; Gouri Rao Passi; Huma Arshad Cheema; Stephanie Efthymiou; Henry Houlden; Aida M Bertoli-Avella; Alice S Brooks; Kyle Retterer; Reza Maroofian; Namik Kaya; Tjakko J van Ham; Tahsin Stefan Barakat
Journal:  Acta Neuropathol       Date:  2019-12-09       Impact factor: 17.088

6.  Epilepsy and BRAF Mutations: Phenotypes, Natural History and Genotype-Phenotype Correlations.

Authors:  Domenica I Battaglia; Maria Luigia Gambardella; Stefania Veltri; Ilaria Contaldo; Giovanni Chillemi; Chiara Veredice; Michela Quintiliani; Chiara Leoni; Roberta Onesimo; Tommaso Verdolotti; Francesca Clementina Radio; Diego Martinelli; Marina Trivisano; Nicola Specchio; Charlotte Dravet; Marco Tartaglia; Giuseppe Zampino
Journal:  Genes (Basel)       Date:  2021-08-26       Impact factor: 4.096

7.  The Genetic Diagnosis of Ultrarare DEEs: An Ongoing Challenge.

Authors:  Luciana Musante; Paola Costa; Caterina Zanus; Flavio Faletra; Flora M Murru; Anna M Bianco; Martina La Bianca; Giulia Ragusa; Emmanouil Athanasakis; Adamo P d'Adamo; Marco Carrozzi; Paolo Gasparini
Journal:  Genes (Basel)       Date:  2022-03-12       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.